Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diamond-Blackfan anemia.

T N Willig1, H Gazda, C A Sieff

  • 1Département de Pédiatrie et Laboratoire d'Hématologie, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, et Faculté Médicine Paris Sud, France.

Current Opinion in Hematology
|March 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical, genetic and histopathologic findings in two siblings with muscle-eye-brain disease.

European journal of ophthalmology·2002
Same author

Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease.

Blood·2001
Same author

Diamond-Blackfan anemia.

Current opinion in pediatrics·2001
Same author

Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain-containing human laminin with high affinity.

Blood·2001
Same author

Congenital bone marrow failure syndromes.

British journal of haematology·2000
Same author

Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells.

Stem cells (Dayton, Ohio)·2000
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Diamond Blackfan anemia, a rare congenital disorder, causes severe anemia in infants. Genetic mutations, particularly in RPS19, are identified in some cases, with prednisone often managing symptoms.

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Diamond Blackfan anemia (DBA) is a rare congenital hypoplastic anemia presenting in infancy.
  • Characterized by moderate to severe macrocytic anemia, erythroid hypoplasia, and potential for leukemia development.
  • Associated congenital anomalies occur in approximately 25% of patients.

Purpose of the Study:

  • To summarize the key features, genetic underpinnings, and treatment outcomes of Diamond Blackfan anemia.
  • To highlight recent genetic discoveries and therapeutic strategies for this rare condition.

Main Methods:

  • Review of existing literature on Diamond Blackfan anemia.
  • Analysis of clinical presentations, genetic findings, and treatment responses.

Related Experiment Videos

Main Results:

  • Mutations in RPS19 gene identified in ~25% of sporadic and familial DBA cases.
  • Prednisone is effective in managing anemia for most patients, though resistance can occur.
  • Bone marrow transplantation offers a curative option for refractory cases.

Conclusions:

  • DBA is a complex genetic disorder with variable clinical presentation and treatment response.
  • Genetic research is advancing understanding of DBA pathogenesis.
  • Multifaceted treatment approaches, including corticosteroids and bone marrow transplantation, are crucial for managing DBA.